The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2017

Filed:

Jun. 10, 2014
Applicants:

The General Hospital Corporation, Boston, MA (US);

The Broad Institute, Inc., Cambridge, MA (US);

University of Kansas, Lawrence, KS (US);

Inventors:

Patrick Faloon, Cambridge, MA (US);

Warren S. Weiner, Phoenix, AZ (US);

Robert A. Smith, Lawrence, KS (US);

Frank John Schoenen, Lawrence, KS (US);

David E. Fisher, Newton, MA (US);

Rizwan Haq, Boston, MA (US);

Assignees:

THE GENERAL HOSPITAL CORPORATION, Boston, MA (US);

THE BROAD INSTITUTE, INC., Cambridge, MA (US);

UNIVERSITY OF KANSAS, Lawrence, KS (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/16 (2006.01); A61K 31/18 (2006.01); C07C 311/17 (2006.01); C07D 333/34 (2006.01); C07D 409/12 (2006.01); C07D 209/48 (2006.01); C07D 307/91 (2006.01); C07D 307/68 (2006.01); A61K 31/4184 (2006.01);
U.S. Cl.
CPC ...
C07C 311/17 (2013.01); A61K 31/4184 (2013.01); C07D 209/48 (2013.01); C07D 307/68 (2013.01); C07D 307/91 (2013.01); C07D 333/34 (2013.01); C07D 409/12 (2013.01);
Abstract

Provided herein are compounds of the formula (IV) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful as MITF inhibitors, MITF pathway inhibitors and for the treatment of cancer.


Find Patent Forward Citations

Loading…